Annual report [Section 13 and 15(d), not S-K Item 405]

Stockholders??? Equity (Tables)

v3.25.1
Stockholders’ Equity (Tables)
 12 Months Ended
Dec. 31, 2024
Equity [Abstract]  
Schedule of Stock Options Activity
The following table summarizes stock options activity during Fiscal 2024 and 2023 (in thousands, except per share data).
Number of Shares Weighted Average Exercise Price Weighted Average Remaining Contractual Life (in years) Total Intrinsic Value
Outstanding as of January 1, 2023 3,952 $ 5.35  3.8 $ 20,379 
Granted 1,135 8.65  5.0 — 
Exercised (1,348) 0.98  —  — 
Forfeited (788) 8.64  —  — 
Outstanding as of December 31, 2023 2,951 7.30  4.8 693 
Granted 1,840 6.01  7.0 — 
Forfeited (910) 7.48  —  — 
Outstanding as of December 31, 2024 3,881 $ 6.64  4.9 $ — 
Options vested and exercisable 2,108 $ 6.55  4.1 $ — 
Summary of Weighted Average Assumptions Used in Determining Fair Value of Options
The following table summarizes weighted average assumptions used in determining the fair value of the stock options at the date of grant during Fiscal 2024 and 2023:
For the years ended
December 31,
2024 2023
Exercise price $ 6.01  $ 8.65 
Expected term (years) 4.5 4.7
Expected stock price volatility 80  % 80  %
Risk-free rate of interest 4.2  % 3.7  %
Expected dividend yield (per share) 0  % 0  %
Schedule of Warrant Activity
The following table summarizes warrant activities during Fiscal 2024 and 2023 (in thousands, except per share data):
Number of Shares Weighted Average
Exercise
Price		 Weighted Average
Remaining Contractual
Life
(in years)
Outstanding as of January 1, 2023 855 $ 8.23  0.9
Warrants granted 376  9.13  4.2
Warrants exercised (400) 3.00 
Outstanding as of December 31, 2023 831 11.16  1.9
Warrants granted 240  0.90  5.0
Warrants expired (455) 12.83 
Outstanding as of December 31, 2024 616 $ 5.93  3.8
Warrants vested and exercisable 376 $ 5.93  3.8